alias:: [[FDC]], [[coformulación]], [[fixed-dose coformulation]], [[fixed-dose combination]]
organization:: [[Liconsa]]
project:: [[STOP2030]]
lead-by:: [[Alejandro Krolewiecki]]
summary:: A combination at fixed doses of ivermectin and albendazole (9mg/400mg & 18mg/400mg) aimed at treating STH, but likely of use for scabies and LF. It has superior efficacy against ALB monotherapy against *T. trichiura* and *S. stercoralis*
status:: Sent for evaluation by EMA (art. 58) and Ghana FDA. Phase IV clinical trial in preparation
- [[FDC/Pharmacokinetics]]
- ## Prequalification at WHO
- Ale, Alan, Julie and Carla are in touch with
- ## Essential Medicines List
-
